REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 19 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,886,774 | +65.9% | 386,634 | +99.2% | 0.00% | – |
| Q2 2023 | $1,137,549 | +220.8% | 194,121 | +129.4% | 0.00% | – |
| Q1 2023 | $354,583 | -35.4% | 84,626 | -34.5% | 0.00% | – |
| Q4 2022 | $549,100 | +57.8% | 129,200 | -40.9% | 0.00% | – |
| Q3 2022 | $348,000 | +1833.3% | 218,532 | +1232.5% | 0.00% | – |
| Q2 2022 | $18,000 | -70.0% | 16,400 | -32.8% | 0.00% | – |
| Q1 2022 | $60,000 | -71.4% | 24,400 | -33.4% | 0.00% | – |
| Q1 2021 | $210,000 | – | 36,652 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 564,000 | $2,752,320 | 0.84% |
| EMC Capital Management | 123,915 | $613 | 0.45% |
| Ikarian Capital, LLC | 5,095 | $2,486,360 | 0.30% |
| SABBY MANAGEMENT, LLC | 44,593 | $217,614 | 0.16% |
| ARMISTICE CAPITAL, LLC | 600,000 | $2,928,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 70,181 | $342 | 0.03% |
| Caption Management, LLC | 275,200 | $1,342,976 | 0.02% |
| Caption Management, LLC | 216,600 | $1,057,008 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 109,700 | $535,336 | 0.01% |
| J. Goldman & Co LP | 75,000 | $366,000 | 0.01% |